Effect of Papaverine on Renal Artery Blood Flow Volume

• Status: Completed
• Trial end date: 2021-04-15
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to evaluate the effect of papaverine on renal artery blood flow after declamping of renal artery.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Asan Medical Center
• Treatments: Papaverine

Criteria

Inclusion Criteria:

• Patients diagnosed with kidney cancer.

• Patients undergoing robot assisted partial nephrectomy under general anesthesia

• 20 years old ≤ age <80 years old

• Patients who voluntarily agreed to this clinical study

• eGFR ≥ 60 ml / min / 1.73 m2 (Chronic Kidney Disease Epidemiology Patients with Collaboration)

Exclusion Criteria:

• The tumor ≥ 7 cm in size

• Multiple renal mass

• If the surgery plan is changed due to open

• When surgery is performed together with other surgery

• Multiple renal artery

• Patients with hypersensitivity to papaverine

• Patients with atrioventricular block

• Pregnant and lactating women

• Patients using levodopa

• Refusal of patient